Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Aluminum Adjuvants and Childhood Disease Prevalence

Version 1 : Received: 22 February 2024 / Approved: 28 February 2024 / Online: 28 February 2024 (08:00:30 CET)

How to cite: Mokeddem, K. Aluminum Adjuvants and Childhood Disease Prevalence. Preprints 2024, 2024021613. https://doi.org/10.20944/preprints202402.1613.v1 Mokeddem, K. Aluminum Adjuvants and Childhood Disease Prevalence. Preprints 2024, 2024021613. https://doi.org/10.20944/preprints202402.1613.v1

Abstract

This study investigated the relationship between aluminum adjuvant vaccines and the prevalence of 4 childhood diseases (Autism, Allergies, Asthma, ADD/ADHD) using data from the 2020-2021 National Survey of Children's Health (NSCH) [1] and the Centers for Disease Control National Immunization Survey (CDC NIS) [2]. The study found an association with aluminum adjuvant dosage and the prevalence of each disease studied (Autism, Allergies, Asthma, ADD/ADHD) through a weighted regression analysis of disease prevalence against the summed likelihood of aluminum adjuvant vaccine uptake.

Keywords

Aluminum Adjuvants; NSCH; NIS-Child

Subject

Medicine and Pharmacology, Epidemiology and Infectious Diseases

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.